In this issue:
Leukaemia selection
Lymphocytosis after dasatinib in CML
High-dose daunorubicin induction in AML across cytogenetic/ molecular groups
β2-microglobulin normalisation after ibrutinib and PFS in CLL
Lymphoma selection
Bleomycin in older early-stage favourable HL
Routine imaging in HL does not improve survival
RIC transplantation for lymphomas using haploidentical vs. matched sibling donors
Outcomes in rituximab-treated de novo CD5+ DLBCL ±SCT
Outcomes following ibrutinib for MCL
QOL differences between BR and R-CHOP/R-CVP in untreated NHL/MCL
MATRix for primary CNS lymphoma
Please login below to download this issue (PDF)